These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32992624)

  • 1. The Prevalence of Multidrug Resistance of
    Park JY; Shin TS; Kim JH; Yoon HJ; Kim BJ; Kim JG
    Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32992624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
    Lee JH; Ahn JY; Choi KD; Jung HY; Kim JM; Baik GH; Kim BW; Park JC; Jung HK; Cho SJ; Shin CM; Choi YJ; Lee SH; Kim JH; Lee WS; Sung JK; Chung JW; Cheung DY; Lee H; Min YW; Kim JJ; Kim SY; ;
    Helicobacter; 2019 Aug; 24(4):e12592. PubMed ID: 31111572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for
    Choi YI; Lee SM; Chung JW; Kim KO; Kwon KA; Kim YJ; Kim JH; Lee SM; Jeong JY; Park DK
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.
    Kim N; Kim JM; Kim CH; Park YS; Lee DH; Kim JS; Jung HC; Song IS
    J Clin Gastroenterol; 2006 Sep; 40(8):683-7. PubMed ID: 16940878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.
    Lee JW; Kim N; Kim JM; Nam RH; Chang H; Kim JY; Shin CM; Park YS; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):206-14. PubMed ID: 23241101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.
    Parra-Sepúlveda C; Merino JS; Sáez-Carrillo K; González C; García-Cancino A
    Arq Gastroenterol; 2019; 56(4):361-366. PubMed ID: 31721972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.
    Lee JY; Kim N; Nam RH; In Choi S; Lee JW; Lee DH
    Helicobacter; 2019 Dec; 24(6):e12660. PubMed ID: 31507036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
    Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
    Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
    Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
    World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
    Dekhnich N; Ivanchik N; Kozlov R; Alimov A; Steshits A; Kirsov P; Pandav K
    Helicobacter; 2018 Dec; 23(6):e12545. PubMed ID: 30324756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
    Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
    Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility testing before first-line treatment for
    Cosme A; Montes M; Ibarra B; Tamayo E; Alonso H; Mendarte U; Lizasoan J; Herreros-Villanueva M; Bujanda L
    World J Gastroenterol; 2017 May; 23(18):3367-3373. PubMed ID: 28566898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
    Lu HH; Lai FP; Lo HY; Sheu BS; Yang YJ
    Helicobacter; 2019 Oct; 24(5):e12633. PubMed ID: 31295754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Antibiotic-Resistant
    Khien VV; Thang DM; Hai TM; Duat NQ; Khanh PH; Ha DT; Binh TT; Dung HDQ; Trang TTH; Yamaoka Y
    Gut Liver; 2019 Sep; 13(5):483-497. PubMed ID: 31009957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant
    Choi YI; Jeong SH; Chung JW; Park DK; Kim KO; Kwon KA; Kim YJ; So S; Lee JH; Jeong JY; Lee SM
    Can J Infect Dis Med Microbiol; 2019; 2019():9351801. PubMed ID: 31360270
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
    Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
    Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance.
    Lee JW; Kim N; Nam RH; Lee SM; Kwon YH; Sohn SD; Kim JM; Lee DH; Jung HC
    Helicobacter; 2019 Apr; 24(2):e12561. PubMed ID: 30632237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
    J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
    Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.